Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.45% | 98.56 | 0.0% | $1438.14m | |
| BIIB | Biogen, Inc. | -0.36% | 242.51 | 1.7% | $630.38m | |
| AMGN | Amgen, Inc. | -0.79% | 220.46 | 1.3% | $568.17m | |
| GILD | Gilead Sciences, Inc. | 0.60% | 60.25 | 1.0% | $535.76m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.63% | 216.50 | 1.9% | $470.81m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -3.34% | 506.10 | 2.7% | $447.76m | |
| BNTX | BioNTech SE | -4.35% | 101.87 | 0.0% | $424.45m | |
| ILMN | Illumina, Inc. | 1.25% | 305.63 | 3.5% | $377.98m | |
| NVAX | Novavax, Inc. | 1.44% | 95.33 | 92.9% | $339.05m | |
| EXAS | EXACT Sciences Corp. | -2.72% | 117.26 | 19.6% | $289.27m | |
| MGEN | Miragen Therapeutics, Inc. | -4.62% | 16.50 | 0.7% | $248.55m | |
| SRRK | Scholar Rock Holding Corp. | 3.14% | 42.70 | 0.0% | $242.63m | |
| APVO | Aptevo Therapeutics, Inc. | -3.58% | 43.92 | 18.3% | $210.20m | |
| SGEN | Seagen Inc. | -2.05% | 164.63 | 5.8% | $167.34m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.41% | 123.11 | 2.0% | $161.56m |
Company Profile
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.